These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 1955853)
21. Mechanism of bacterial resistance to complement-mediated killing: inserted C5b-9 correlates with killing for Escherichia coli O111B4 varying in O-antigen capsule and O-polysaccharide coverage of lipid A core oligosaccharide. Joiner KA; Schmetz MA; Goldman RC; Leive L; Frank MM Infect Immun; 1984 Jul; 45(1):113-7. PubMed ID: 6203836 [TBL] [Abstract][Full Text] [Related]
22. Sialic acid-containing lipopolysaccharides of Salmonella O48 strains--potential role in camouflage and susceptibility to the bactericidal effect of normal human serum. Bugla-Płoskońska G; Rybka J; Futoma-Kołoch B; Cisowska A; Gamian A; Doroszkiewicz W Microb Ecol; 2010 Apr; 59(3):601-13. PubMed ID: 19844648 [TBL] [Abstract][Full Text] [Related]
23. Role of lipopolysaccharide and complement in susceptibility of Haemophilus ducreyi to human serum. Odumeru JA; Wiseman GM; Ronald AR Infect Immun; 1985 Nov; 50(2):495-9. PubMed ID: 3876995 [TBL] [Abstract][Full Text] [Related]
24. Molecular and chemical analysis of the lipopolysaccharide from Aeromonas hydrophila strain AH-1 (Serotype O11). Merino S; Canals R; Knirel YA; Tomás JM Mar Drugs; 2015 Apr; 13(4):2233-49. PubMed ID: 25874921 [TBL] [Abstract][Full Text] [Related]
25. The role of O-antigen in susceptibility of Serratia marcescens to non-immune serum. Palomar J; Montilla R; Fusté MC; Viñas M Microbios; 1993; 76(308):189-96. PubMed ID: 8302200 [TBL] [Abstract][Full Text] [Related]
26. Use of a bacteriophage-encoded glycanase enzyme in the generation of lipopolysaccharide O side chain deficient mutants of Escherichia coli O9:K30 and Klebsiella O1:K20: role of O and K antigens in resistance to complement-mediated serum killing. McCallum KL; Laakso DH; Whitfield C Can J Microbiol; 1989 Nov; 35(11):994-9. PubMed ID: 2482125 [TBL] [Abstract][Full Text] [Related]
27. Pathogenic Aeromonas hydrophila serogroup O:14 and O:81 strains with an S layer. Esteve C; Alcaide E; Canals R; Merino S; Blasco D; Figueras MJ; Tomás JM Appl Environ Microbiol; 2004 Oct; 70(10):5898-904. PubMed ID: 15466530 [TBL] [Abstract][Full Text] [Related]
28. Human complement activation by smooth and rough Proteus mirabilis lipopolysaccharides. Kaca W; Arabski M; Fudała R; Holmström E; Sjöholm A; Weintraub A; Futoma-Kołoch B; Bugla-Płoskońska G; Doroszkiewicz W Arch Immunol Ther Exp (Warsz); 2009; 57(5):383-91. PubMed ID: 19707721 [TBL] [Abstract][Full Text] [Related]
30. Assembly of the membrane attack complex promotes decay of the alternative pathway C3 convertase on Neisseria gonorrhoeae. Densen P; McRill CM; Ross SC J Immunol; 1988 Dec; 141(11):3902-9. PubMed ID: 3141507 [TBL] [Abstract][Full Text] [Related]
31. Melanization and pathogenicity in the insect, Tenebrio molitor, and the crustacean, Pacifastacus leniusculus, by Aeromonas hydrophila AH-3. Noonin C; Jiravanichpaisal P; Söderhäll I; Merino S; Tomás JM; Söderhäll K PLoS One; 2010 Dec; 5(12):e15728. PubMed ID: 21206752 [TBL] [Abstract][Full Text] [Related]
32. Role of lipopolysaccharide and complement in susceptibility of Klebsiella pneumoniae to nonimmune serum. Ciurana B; Tomás JM Infect Immun; 1987 Nov; 55(11):2741-6. PubMed ID: 3312009 [TBL] [Abstract][Full Text] [Related]
33. Determination of distinctive carbohydrate signatures obtained from the Aeromonas hydrophila (chemotype II) core oligosaccharide pinpointing the presence of the 4-O-phosphorylated 5-O-linked Kdo reducing end group using electrospray ionization quadrupole orthogonal time-of-flight mass spectrometry and tandem mass spectrometry. Sioud S; Jahouh F; Nashed M; Joly N; Banoub JH Rapid Commun Mass Spectrom; 2010 Sep; 24(17):2475-90. PubMed ID: 20740521 [TBL] [Abstract][Full Text] [Related]
34. Isolation and characterization of bacteriophage PM2 from Aeromonas hydrophila. Merino S; Camprubi S; Tomás JM FEMS Microbiol Lett; 1990 Mar; 56(3):239-44. PubMed ID: 2341024 [TBL] [Abstract][Full Text] [Related]
35. Serum-resistant mutants of Escherichia coli O111 contain increased lipopolysaccharide, lack an O antigen-containing capsule, and cover more of their lipid A core with O antigen. Goldman RC; Joiner K; Leive L J Bacteriol; 1984 Sep; 159(3):877-82. PubMed ID: 6207166 [TBL] [Abstract][Full Text] [Related]
36. Complement processing and immunoglobulin binding to Neisseria gonorrhoeae determined in vitro simulates in vivo effects. McQuillen DP; Gulati S; Ram S; Turner AK; Jani DB; Heeren TC; Rice PA J Infect Dis; 1999 Jan; 179(1):124-35. PubMed ID: 9841831 [TBL] [Abstract][Full Text] [Related]
37. Lipopolysaccharide phase variation determines the complement-mediated serum susceptibility of Coxiella burnetii. Vishwanath S; Hackstadt T Infect Immun; 1988 Jan; 56(1):40-4. PubMed ID: 3335408 [TBL] [Abstract][Full Text] [Related]
38. Bactericidal, bacteriolytic and opsonic activity of human serum against Escherichia coli. Rozenberg-Arska M; Porsius JC; Jaarsma EY; Verhoef J J Med Microbiol; 1986 Sep; 22(2):143-9. PubMed ID: 3528498 [TBL] [Abstract][Full Text] [Related]
39. Differences among Shigella spp. in susceptibility to the bactericidal activity of human serum. Okamura N; Nakaya R; Suzuki K; Kondo S; Hisatsune K; Imagawa Y; Sagara H; Matsubara Y J Gen Microbiol; 1988 Jul; 134(7):2057-65. PubMed ID: 3246597 [TBL] [Abstract][Full Text] [Related]